What is Cross Ctry Healthcare Inc's earnings per share (EPS)?

Cross Ctry Healthcare Inc (CCRN) reported diluted earnings per share of $-2.93 for fiscal year 2025. This represents a -565.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cross Ctry Healthcare Inc Financials

CCRN

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE December

This page shows Cross Ctry Healthcare Inc (CCRN) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CCRN FY2025 2026-05-08

Revenue contraction is outrunning cost cuts, while working-capital release is still keeping reported cash generation and liquidity positive.

FY2025 still produced $40.1M of free cash flow despite a -$94.9M net loss, which points to working-capital release rather than durable earnings quality. The clearest driver is receivables unwinding: accounts receivable fell to $167.5M from $223.2M as revenue contracted, so cash conversion improved because old billings were collected faster than new ones were created.

The cost base is not flexing as quickly as volume: SG&A consumed 19.0% of sales in FY2025 versus 14.9% in FY2023, which helps explain why operating losses widened as revenue reset lower. That pattern points to negative operating leverage—the business was built for a larger revenue base, so each lost dollar now removes more contribution than expenses are giving back.

Liquidity looks stronger than earnings alone would imply: cash ended FY2025 at $108.7M against current liabilities of $77.8M, and total liabilities have been stepping down for two straight years. That creates balance-sheet cushioning and helps explain why the company could keep repurchasing shares despite losses; the visible stress is in profitability and scale, not in immediate short-term funding needs.

Financial Health Signals

Financial Health Score 42/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cross Ctry Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cross Ctry Healthcare Inc has an operating margin of -8.0%, meaning the company retains $-8 of operating profit per $100 of revenue. This below-average margin results in a low score of 26/100, suggesting thin profitability after operating expenses. This is down from -1.3% the prior year.

Growth

Cross Ctry Healthcare Inc's revenue declined 21.6% year-over-year, from $1.3B to $1.1B. This contraction results in a growth score of 3/100.

Leverage

Cross Ctry Healthcare Inc has a moderate D/E ratio of 0.39. This balance of debt and equity financing earns a leverage score of 64/100.

Liquidity

With a current ratio of 3.78, Cross Ctry Healthcare Inc holds $3.78 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 84/100.

Cash Flow

Cross Ctry Healthcare Inc has a free cash flow margin of 3.8%, earning a moderate score of 55/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Cross Ctry Healthcare Inc generates a -29.4% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 22/100. This is down from -3.5% the prior year.

Altman Z-Score Safe

4.72

Cross Ctry Healthcare Inc scores 4.72, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/7

Cross Ctry Healthcare Inc passes 5 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 2 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Mixed

-0.51x

For every $1 of reported earnings, Cross Ctry Healthcare Inc generates $-0.51 in operating cash flow ($48.3M OCF vs -$94.9M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-38.1x

Cross Ctry Healthcare Inc earns $-38.1 in operating income for every $1 of interest expense (-$84.4M vs $2.2M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.1B

YoY-21.6%

5Y CAGR+4.7%

10Y CAGR+3.2%

Cross Ctry Healthcare Inc generated $1.1B in revenue in fiscal year 2025. This represents a decrease of 21.6% from the prior year.

EBITDA

-$67.6M

YoY-5165.2%

Cross Ctry Healthcare Inc's EBITDA was -$67.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 5165.2% from the prior year.

Net Income

-$94.9M

YoY-551.6%

Cross Ctry Healthcare Inc reported -$94.9M in net income in fiscal year 2025. This represents a decrease of 551.6% from the prior year.

EPS (Diluted)

$-2.93

YoY-565.9%

Cross Ctry Healthcare Inc earned $-2.93 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 565.9% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$40.1M

YoY-64.0%

5Y CAGR+12.2%

10Y CAGR+9.7%

Cross Ctry Healthcare Inc generated $40.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 64.0% from the prior year.

Cash & Debt

$108.7M

YoY+33.2%

5Y CAGR+132.5%

10Y CAGR+46.1%

Cross Ctry Healthcare Inc held $108.7M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

32M

YoY-1.7%

5Y CAGR-2.6%

10Y CAGR-0.1%

Cross Ctry Healthcare Inc had 32M shares outstanding in fiscal year 2025. This represents a decrease of 1.7% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

-8.0%

YoY-6.8pp

5Y CAGR-6.9pp

10Y CAGR-10.7pp

Cross Ctry Healthcare Inc's operating margin was -8.0% in fiscal year 2025, reflecting core business profitability. This is down 6.8 percentage points from the prior year.

Net Margin

-9.0%

YoY-7.9pp

5Y CAGR-7.4pp

10Y CAGR-9.6pp

Cross Ctry Healthcare Inc's net profit margin was -9.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 7.9 percentage points from the prior year.

Return on Equity

-29.4%

YoY-25.9pp

5Y CAGR-21.0pp

10Y CAGR-32.5pp

Cross Ctry Healthcare Inc's ROE was -29.4% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 25.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$6.8M

YoY-81.7%

Cross Ctry Healthcare Inc spent $6.8M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 81.7% from the prior year.

Capital Expenditures

$8.2M

YoY-6.3%

5Y CAGR+12.1%

10Y CAGR+13.2%

Cross Ctry Healthcare Inc invested $8.2M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 6.3% from the prior year.

CCRN Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.1B-21.6%	$1.3B-33.5%	$2.0B-28.0%	$2.8B+67.2%	$1.7B+100.5%	$836.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$200.7M-14.0%	$233.4M-22.3%	$300.3M-7.4%	$324.2M+49.8%	$216.4M+24.5%	$173.8M
Operating Income	-$84.4M-400.5%	-$16.9M-115.0%	$112.7M-58.2%	$269.9M+93.7%	$139.3M+1620.8%	-$9.2M
Interest Expense	$2.2M+1.3%	$2.2M-73.0%	$8.1M-43.8%	$14.4M+109.6%	$6.9M+137.6%	$2.9M
Income Tax	$11.3M+715.7%	-$1.8M-106.1%	$30.3M-54.9%	$67.1M+5465.1%	$1.2M+741.5%	-$188K
Net Income	-$94.9M-551.6%	-$14.6M-120.0%	$72.6M-61.5%	$188.5M+42.8%	$132.0M+1118.4%	-$13.0M
EPS (Diluted)	$-2.93-565.9%	$-0.44-121.5%	$2.05-58.6%	$4.95+40.2%	$3.53+1080.6%	$-0.36

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$241.1M+1.8%	$236.8M-5.3%	$250.1M-8.8%	$274.1M-6.6%	$293.4M-5.3%	$309.9M-1.6%	$315.1M-7.3%	$339.8M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$48.0M-5.8%	$50.9M-9.1%	$56.0M-4.5%	$58.7M-5.4%	$62.0M-3.4%	$64.2M-9.4%	$70.8M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$45.8M	N/A	$46.9M-6.3%	$50.0M-4.6%	$52.5M	N/A	$54.3M-9.9%	$60.3M
Operating Income	-$4.2M	N/A	-$6.0M-1.9%	-$5.9M-499.7%	-$977K	N/A	$2.9M+114.9%	-$19.2M
Interest Expense	$567K	N/A	$556K+1.3%	$549K+1.1%	$543K	N/A	$550K-3.2%	$568K
Income Tax	$532K	N/A	-$863K-192.8%	$930K+327.4%	-$409K	N/A	$834K+123.7%	-$3.5M
Net Income	-$4.3M+94.9%	-$82.9M-1637.1%	-$4.8M+28.3%	-$6.7M-1259.0%	-$490K+86.9%	-$3.8M-246.9%	$2.6M+115.9%	-$16.1M
EPS (Diluted)	$-0.14+94.5%	$-2.56-1606.7%	$-0.15+25.0%	$-0.20-900.0%	$-0.02+83.3%	$-0.12-250.0%	$0.08+117.0%	$-0.47

CCRN Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$449.0M-23.8%	$589.3M-13.5%	$681.1M-28.3%	$949.6M+29.6%	$732.8M+105.3%	$357.0M
Current Assets	$293.6M-12.4%	$335.0M-19.6%	$416.9M-38.5%	$677.4M+33.3%	$508.3M+177.6%	$183.1M
Cash & Equivalents	$108.7M+33.2%	$81.6M+377.6%	$17.1M+374.3%	$3.6M+247.9%	$1.0M-35.3%	$1.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$167.5M-25.0%	$223.2M-40.0%	$372.4M-42.0%	$641.6M+29.9%	$493.9M+190.5%	$170.0M
Goodwill	$63.8M-52.8%	$135.1M-0.3%	$135.4M-17.1%	$163.3M+36.6%	$119.5M+31.4%	$90.9M
Total Liabilities	$126.1M-25.9%	$170.3M-20.2%	$213.4M-57.2%	$498.1M+14.4%	$435.3M+115.4%	$202.1M
Current Liabilities	$77.8M-35.4%	$120.4M-22.9%	$156.1M-44.1%	$279.1M+39.7%	$199.8M+113.8%	$93.4M
Long-Term Debt	N/A	N/A	N/A	$150.7M-17.1%	$181.8M+225.5%	$55.8M
Total Equity	$322.8M-22.9%	$419.0M-10.4%	$467.7M+3.6%	$451.5M+53.4%	$294.3M+90.6%	$154.4M
Retained Earnings	$123.2M-43.5%	$218.1M-6.3%	$232.6M+45.4%	$160.0M+803.7%	-$22.7M+85.3%	-$154.7M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$451.1M+0.5%	$449.0M-16.6%	$538.2M-2.8%	$553.8M-3.9%	$576.2M-2.2%	$589.3M-1.4%	$597.4M-0.9%	$602.9M
Current Assets	$298.3M+1.6%	$293.6M-0.5%	$295.1M-4.5%	$309.1M-5.0%	$325.2M-2.9%	$335.0M-0.5%	$336.6M-0.3%	$337.8M
Cash & Equivalents	$105.6M-2.9%	$108.7M+9.7%	$99.1M+22.1%	$81.2M+0.6%	$80.7M-1.1%	$81.6M+27.5%	$64.0M-8.0%	$69.6M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$176.6M+5.4%	$167.5M-7.0%	$180.2M-10.7%	$201.7M-8.2%	$219.8M-1.5%	$223.2M-8.9%	$245.0M+1.1%	$242.3M
Goodwill	$63.8M0.0%	$63.8M-52.8%	$135.1M0.0%	$135.1M0.0%	$135.1M0.0%	$135.1M-0.3%	$135.4M0.0%	$135.4M
Total Liabilities	$138.3M+9.6%	$126.1M-3.0%	$130.1M-8.1%	$141.6M-10.4%	$158.0M-7.2%	$170.3M-1.4%	$172.7M+5.4%	$163.8M
Current Liabilities	$90.6M+16.5%	$77.8M-9.1%	$85.5M-11.0%	$96.2M-11.8%	$109.0M-9.4%	$120.4M-0.2%	$120.7M+9.6%	$110.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$312.8M-3.1%	$322.8M-20.9%	$408.1M-1.0%	$412.2M-1.4%	$418.2M-0.2%	$419.0M-1.3%	$424.7M-2.0%	$433.3M
Retained Earnings	$118.9M-3.5%	$123.2M-40.2%	$206.1M-2.3%	$210.9M-3.1%	$217.6M-0.2%	$218.1M-1.7%	$221.8M-1.4%	$225.0M

CCRN Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$48.3M-59.8%	$120.1M-51.7%	$248.5M+85.4%	$134.1M+256.6%	-$85.6M-414.7%	$27.2M
Capital Expenditures	$8.2M-6.3%	$8.7M-37.6%	$14.0M+59.0%	$8.8M+22.5%	$7.2M+55.4%	$4.6M
Free Cash Flow	$40.1M-64.0%	$111.4M-52.5%	$234.5M+87.2%	$125.3M+235.0%	-$92.8M-510.8%	$22.6M
Investing Cash Flow	-$8.2M+6.3%	-$8.7M+36.7%	-$13.8M+68.6%	-$43.9M-28.9%	-$34.0M-637.7%	-$4.6M
Financing Cash Flow	-$13.0M+72.2%	-$46.8M+78.8%	-$221.2M-152.6%	-$87.6M-173.6%	$119.1M+641.1%	-$22.0M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$6.8M-81.7%	$37.3M-35.3%	$57.7M+63.4%	$35.3M	$0	$0

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$4.8M-73.9%	$18.2M-9.3%	$20.1M+377.0%	$4.2M-25.8%	$5.7M-76.6%	$24.2M+224.4%	$7.5M-90.9%	$82.4M
Capital Expenditures	$1.5M-31.1%	$2.1M-3.4%	$2.2M+11.4%	$2.0M+4.3%	$1.9M-25.5%	$2.5M+125.2%	$1.1M-60.5%	$2.8M
Free Cash Flow	$3.3M-79.5%	$16.1M-10.0%	$17.9M+696.6%	$2.3M-40.7%	$3.8M-82.5%	$21.7M+242.0%	$6.3M-92.0%	$79.6M
Investing Cash Flow	-$1.5M+31.1%	-$2.1M+3.4%	-$2.2M-11.4%	-$2.0M-4.3%	-$1.9M+25.5%	-$2.5M-125.2%	-$1.1M+60.5%	-$2.8M
Financing Cash Flow	-$6.5M+1.0%	-$6.5M-108550.0%	-$6K+99.7%	-$1.8M+62.8%	-$4.7M-15.9%	-$4.1M+65.8%	-$11.9M+21.5%	-$15.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$5.9M-10.0%	$6.5M	$0	$0-100.0%	$314K-92.3%	$4.1M-65.8%	$11.9M-20.2%	$14.9M

CCRN Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-8.0%-6.8pp	-1.3%-6.8pp	5.6%-4.0pp	9.6%+1.3pp	8.3%+9.4pp	-1.1%
Net Margin	-9.0%-7.9pp	-1.1%-4.7pp	3.6%-3.1pp	6.7%-1.2pp	7.9%+9.4pp	-1.6%
Return on Equity	-29.4%-25.9pp	-3.5%-19.0pp	15.5%-26.2pp	41.7%-3.1pp	44.9%+53.3pp	-8.4%
Return on Assets	-21.1%-18.7pp	-2.5%-13.1pp	10.7%-9.2pp	19.9%+1.8pp	18.0%+21.6pp	-3.6%
Current Ratio	3.78+1.0	2.78+0.1	2.67+0.2	2.43-0.1	2.54+0.6	1.96
Debt-to-Equity	0.39-0.0	0.41-0.0	0.46+0.1	0.33-0.3	0.62+0.3	0.36
FCF Margin	3.8%-4.5pp	8.3%-3.3pp	11.6%+7.1pp	4.5%+10.0pp	-5.5%-8.2pp	2.7%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	20.3%-0.1pp	20.4%-0.1pp	20.4%+0.4pp	20.0%-0.0pp	20.0%-0.4pp	20.4%-0.5pp	20.8%
Operating Margin	-1.7%	N/A	-2.4%-0.3pp	-2.1%-1.8pp	-0.3%	N/A	0.9%+6.6pp	-5.7%
Net Margin	-1.8%+33.3pp	-35.0%-33.1pp	-1.9%+0.5pp	-2.4%-2.3pp	-0.2%+1.0pp	-1.2%-2.0pp	0.8%+5.5pp	-4.7%
Return on Equity	-1.4%+24.3pp	-25.7%-24.5pp	-1.2%+0.4pp	-1.6%-1.5pp	-0.1%+0.8pp	-0.9%-1.5pp	0.6%+4.3pp	-3.7%
Return on Assets	-0.9%+17.5pp	-18.5%-17.6pp	-0.9%+0.3pp	-1.2%-1.1pp	-0.1%+0.6pp	-0.6%-1.1pp	0.4%+3.1pp	-2.7%
Current Ratio	3.29-0.5	3.78+0.3	3.45+0.2	3.21+0.2	2.98+0.2	2.780.0	2.79-0.3	3.07
Debt-to-Equity	0.44+0.1	0.39+0.1	0.32-0.0	0.34-0.0	0.38-0.0	0.410.0	0.41+0.0	0.38
FCF Margin	1.4%-5.4pp	6.8%-0.4pp	7.2%+6.3pp	0.8%-0.5pp	1.3%-5.7pp	7.0%+5.0pp	2.0%-21.4pp	23.4%

Similar Companies

Community Health Sys Inc CYH

$490.4M

Enhabit EHAB

$706.9M

AUNA S.A. AUNA

$388.8M

Airsculpt Technologies, Inc. AIRS

$296.3M

Nutex Health Inc NUTX

$1.2B

Frequently Asked Questions

What is Cross Ctry Healthcare Inc's annual revenue?

Cross Ctry Healthcare Inc (CCRN) reported $1.1B in total revenue for fiscal year 2025. This represents a -21.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cross Ctry Healthcare Inc's revenue growing?

Cross Ctry Healthcare Inc (CCRN) revenue declined by 21.6% year-over-year, from $1.3B to $1.1B in fiscal year 2025.

Is Cross Ctry Healthcare Inc profitable?

No, Cross Ctry Healthcare Inc (CCRN) reported a net income of -$94.9M in fiscal year 2025, with a net profit margin of -9.0%.

What is Cross Ctry Healthcare Inc's EBITDA?

Cross Ctry Healthcare Inc (CCRN) had EBITDA of -$67.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Cross Ctry Healthcare Inc's operating margin?

Cross Ctry Healthcare Inc (CCRN) had an operating margin of -8.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cross Ctry Healthcare Inc's net profit margin?

Cross Ctry Healthcare Inc (CCRN) had a net profit margin of -9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Cross Ctry Healthcare Inc's return on equity (ROE)?

Cross Ctry Healthcare Inc (CCRN) has a return on equity of -29.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cross Ctry Healthcare Inc's free cash flow?

Cross Ctry Healthcare Inc (CCRN) generated $40.1M in free cash flow during fiscal year 2025. This represents a -64.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cross Ctry Healthcare Inc's operating cash flow?

Cross Ctry Healthcare Inc (CCRN) generated $48.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Cross Ctry Healthcare Inc's total assets?

Cross Ctry Healthcare Inc (CCRN) had $449.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cross Ctry Healthcare Inc's capital expenditures?

Cross Ctry Healthcare Inc (CCRN) invested $8.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Cross Ctry Healthcare Inc buy back shares?

Yes, Cross Ctry Healthcare Inc (CCRN) spent $6.8M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cross Ctry Healthcare Inc have outstanding?

Cross Ctry Healthcare Inc (CCRN) had 32M shares outstanding as of fiscal year 2025.

What is Cross Ctry Healthcare Inc's current ratio?

Cross Ctry Healthcare Inc (CCRN) had a current ratio of 3.78 as of fiscal year 2025, which is generally considered healthy.

What is Cross Ctry Healthcare Inc's debt-to-equity ratio?

Cross Ctry Healthcare Inc (CCRN) had a debt-to-equity ratio of 0.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cross Ctry Healthcare Inc's return on assets (ROA)?

Cross Ctry Healthcare Inc (CCRN) had a return on assets of -21.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cross Ctry Healthcare Inc's Altman Z-Score?

Cross Ctry Healthcare Inc (CCRN) has an Altman Z-Score of 4.72, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Cross Ctry Healthcare Inc's Piotroski F-Score?

Cross Ctry Healthcare Inc (CCRN) has a Piotroski F-Score of 5 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cross Ctry Healthcare Inc's earnings high quality?

Cross Ctry Healthcare Inc (CCRN) has an earnings quality ratio of -0.51x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Cross Ctry Healthcare Inc cover its interest payments?

Cross Ctry Healthcare Inc (CCRN) has an interest coverage ratio of -38.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Cross Ctry Healthcare Inc?

Cross Ctry Healthcare Inc (CCRN) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.